‏إظهار الرسائل ذات التسميات Blinkit. إظهار كافة الرسائل
‏إظهار الرسائل ذات التسميات Blinkit. إظهار كافة الرسائل

Blinkit Faces Maharashtra FDA Action as 18,405 Expired Food Items Are Detected

Blinkit Faces Maharashtra FDA Action as 18,405 Expired Food Items Are Detected

The Maharashtra Food and Drug Administration (FDA) has suspended the food business licence of Blinkit’s Bhiwandi facility after inspectors allegedly found major lapses in the handling and disposal of expired, damaged and rejected food products. The action follows an inspection that uncovered 18,405 food items worth more than ₹32.71 lakh for which the company could not provide adequate traceability records or proof of destruction.

What Triggered the FDA Action?

According to Maharashtra FDA officials, an inspection conducted on 21 October at Blinkit's warehouse facility in Bhiwandi, Maharashtra, revealed that the company was unable to provide end-to-end traceability and documentation showing the disposal of approximately 18,405 expired, damaged or rejected food products valued at more than ₹32.71 lakh.

Regulators stated that the absence of proper records raised concerns about whether the inventory had been safely destroyed as required under food safety regulations. As a result, the FDA ordered the immediate suspension of licensed food operations at the premises.

Public Health Concerns at the Centre

The FDA said its primary concern was the possibility that food items classified as unsaleable could potentially re-enter the consumer market. Officials argued that expired or damaged products pose a direct risk to public health if they are diverted back into commercial channels instead of being scientifically destroyed.

The regulator described the situation as a serious compliance failure because businesses handling food products are required to maintain complete records regarding the storage, movement and destruction of non-saleable inventory.

FIR Filed Against Executives and Vendors

The matter has gone beyond regulatory action and entered the criminal investigation stage.

Following the licence suspension, the Maharashtra FDA registered an FIR at Bhiwandi Taluka Police Station against key Blinkit personnel, including a whole-time director, facility managers and several scrap-disposal vendors.

The accused have reportedly been booked under provisions of the Bharatiya Nyaya Sanhita (BNS), 2023, including sections related to cheating and criminal conspiracy, along with Section 59(i) of the Food Safety and Standards Act, 2006. Authorities have alleged a conspiracy involving the possible resale of expired food products for financial gain. These allegations remain under investigation, and the filing of an FIR does not establish guilt.

Why Bhiwandi Matters

The development is significant because Bhiwandi is one of India's largest warehousing and logistics hubs, serving e-commerce companies, retailers and quick-commerce platforms. The region houses large fulfilment centres that support rapid delivery operations across Mumbai and neighbouring markets.

Any disruption in operations at a major warehouse can have implications for inventory management and supply-chain processes, particularly in the fast-growing quick-commerce industry where speed and inventory turnover are critical.

Part of a Wider FDA Crackdown

The action against Blinkit appears to be part of a broader enforcement drive by the Maharashtra FDA under Food and Drug Administration Commissioner Tukaram Mundhe. The regulator has recently intensified inspections of warehouses, dark stores and waste-disposal networks amid concerns that expired or rejected food products may be finding their way back into retail channels.

Authorities have conducted multiple raids targeting suspected diversion networks and have reportedly booked several individuals connected to food companies, disposal agencies and local traders in related investigations.

A Fresh Setback for Blinkit

The latest suspension comes just months after another FDA action involving a Blinkit facility in Mumbai's Malad area, where inspectors reported hygiene and food-safety violations, including the presence of expired products and poor storage conditions.

While the Bhiwandi case centres on inventory traceability and disposal records rather than hygiene issues, both incidents underscore increasing regulatory scrutiny of quick-commerce operators that handle large volumes of food products.

Industry-Wide Implications

The Maharashtra FDA's action signals a tougher regulatory stance toward food inventory management across the e-commerce and quick-commerce ecosystem. The case highlights the growing importance of:
  • Maintaining complete traceability of food products.
  • Proper destruction of expired and damaged inventory.
  • Robust record-keeping and compliance systems.
  • Preventing unsaleable food stock from re-entering the market.
  • Strengthening oversight of third-party disposal vendors.
As investigations continue, regulators are expected to closely monitor how food businesses manage expired inventory and comply with food safety norms.

Conclusion

The suspension of Blinkit's Bhiwandi food licence marks one of the most significant enforcement actions taken by the Maharashtra FDA against a quick-commerce operator in recent months. With 18,405 food items worth ₹32.71 lakh at the centre of the case, and an FIR now lodged against company personnel and vendors, the investigation could become a defining test of inventory traceability and food-safety compliance standards within India's rapidly expanding quick-commerce sector.

Blinkit Secures ₹450 Cr Infusion from Eternal in 2026’s First Funding Round

Blinkit Secures ₹450 Cr Infusion from Eternal in 2026’s First Funding Round

Eternal (formerly Zomato) has infused ₹450 crore (~$50 million) into its quick commerce arm Blinkit via a rights issue, marking its first capital injection in 2026. This follows a massive ₹2,600 crore investment in 2025, underscoring Eternal’s aggressive push to dominate India’s fast-growing 10-minute delivery market.

Key Highlights

  • Amount Invested: ₹450 crore (~$50 million)
  • Mode: Rights issue; Blinkit allotted 2,799 equity shares to Eternal at ₹16,07,161 per share
  • Timing: First capital infusion in 2026
  • Past Investments: Eternal pumped ₹2,600 crore in 2025 (₹500 crore in Jan, ₹1,500 crore in Feb, ₹600 crore in Nov)
  • Competition: Rising rivalry with Zepto and Instamart in the quick commerce space

Strategic Context

  • Market Dynamics: Quick commerce is one of India’s fastest-growing segments, with 10-minute delivery becoming the industry benchmark.
  • Blinkit’s Growth: Reported 117% YoY revenue growth in Q3 FY25, but continues to face profitability pressures due to rapid expansion and high operational costs.
  • Eternal’s Strategy: By consistently infusing capital, Eternal is signaling long-term commitment to Blinkit, positioning it as a core pillar alongside food delivery.

Comparison of Eternal’s Investments in Blinkit

Year Infusion Amount Mode Strategic Intent
2025 ₹2,600 crore (3 tranches) Rights issue Scale operations, expand delivery network
2026 ₹450 crore Rights issue Strengthen position amid intensifying competition

Risks & Challenges

  • Profitability Concerns: Despite revenue growth, Blinkit’s unit economics remain weak, with high delivery costs.
  • Competitive Pressure: Zepto and Instamart are aggressively expanding, forcing Eternal to keep investing heavily.
  • Capital Dependence: Blinkit’s reliance on Eternal’s funding raises questions about sustainability if external capital markets tighten.
India’s quick commerce sector is booming, with Blinkit, Zepto, and Instamart competing for dominance. Zepto and Instamart are expanding aggressively, forcing Eternal to keep funding Blinkit’s growth. Despite strong revenue growth (117% YoY in Q3 FY25), Blinkit continues to face challenges with unit economics and high delivery costs.

Blinkit’s reliance on Eternal’s capital raises sustainability concerns. Zepto and Instamart’s expansion could erode Blinkit’s market share if Eternal slows funding.

Despite revenue growth, Blinkit’s path to profitability remains uncertain. Eternal must balance aggressive expansion with profitability, as rivals are raising funds and scaling rapidly.

In 2026, as Eternal has already infused ₹450 crore into Blinkit, its rivals Zepto and Swiggy Instamart are pursuing aggressive funding and IPO strategies. Zepto is preparing for a ₹11,000 crore IPO, and Swiggy is targeting Instamart break-even by mid-2026 despite heavy losses.

Zepto (2026)

  • Funding: Raised $450M (~₹3,750 Cr) in late 2025 at a $7B valuation, led by CalPERS.
  • IPO Plans: Filed confidential DRHP with SEBI, aiming for a ₹11,000 crore IPO in 2026 at $7–8B valuation.
  • Cash Position: Holds ~$900M net cash, giving strong liquidity ahead of IPO.

Swiggy Instamart (2026)

  • Financials: Reported ₹908 Cr loss in Q3 FY26, highlighting profitability challenges.
  • Growth: Gross Order Value (GOV) grew 108% YoY, with Average Order Value (AOV) up 26% YoY.
  • Profitability Target: Swiggy aims for Instamart break-even by June 2026, supported by a planned ₹10,000 crore fundraise.

Competitive Snapshot

Company 2026 Update Funding/IPO Strategic Focus
Eternal–Blinkit ₹450 Cr infusion (Mar 2026) Rights issue Expansion, working capital
Zepto Preparing IPO ₹11,000 Cr IPO planned Liquidity & market leadership
Swiggy Instamart ₹908 Cr Q3 FY26 loss ₹10,000 Cr fundraise Break-even by June 2026

Risks & Challenges

  • Eternal–Blinkit: Heavy reliance on Eternal’s capital; profitability remains elusive.
  • Zepto: IPO execution risk; valuation pressure in volatile markets.
  • Instamart: Large losses despite growth; break-even target ambitious.

Market Reports

Market Report & Surveys
IndianWeb2.com © all rights reserved